Your browser doesn't support javascript.
loading
Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021.
Bagamian, Karoun H; Puett, Chloe; Anderson, John D; Muhib, Farzana; Pecenka, Clint; Behrman, Jere; Breiman, Robert F; Edoka, Ijeoma; Horton, Susan; Kang, Gagandeep; Kotloff, Karen L; Lanata, Claudio F; Platts-Mills, James A; Qadri, Firdausi; Rogawski McQuade, Elizabeth T; Sudfeld, Christopher; Vonaesch, Pascale; Wierzba, Thomas F; Scheele, Suzanne.
Affiliation
  • Bagamian KH; Bagamian Scientific Consulting, LLC, Gainesville, FL 32601, USA.
  • Puett C; Department of Environmental and Global Health, University of Florida, Gainesville, FL 32603, USA.
  • Anderson JD; Stony Brook University, Department of Family, Population & Preventative Medicine, Program in Public Health, Stony Brook, NY 11794, USA.
  • Muhib F; Bagamian Scientific Consulting, LLC, Gainesville, FL 32601, USA.
  • Pecenka C; Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Ave NW, Washington, DC 20001, USA.
  • Behrman J; Center for Vaccine Innovation and Access, PATH, Seattle, WA 98121, USA.
  • Breiman RF; Department of Economics and Sociology, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Edoka I; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
  • Horton S; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Kang G; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Kotloff KL; School of Public Health Sciences, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
  • Lanata CF; Division of Gastrointestinal Sciences, Christian Medical College, Vellore 632004, India.
  • Platts-Mills JA; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Qadri F; Instituto de Investigacion Nutricional, Lima, Peru.
  • Rogawski McQuade ET; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, VA 22903, USA.
  • Sudfeld C; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
  • Vonaesch P; Department of Epidemiology, Emory University, Atlanta, GA 30322, USA.
  • Wierzba TF; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
  • Scheele S; Department of Fundamental Microbiology, University of Lausanne, Switzerland.
Vaccine X ; 12: 100218, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36237199

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Aspects: Patient_preference Language: En Journal: Vaccine X Year: 2022 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Aspects: Patient_preference Language: En Journal: Vaccine X Year: 2022 Document type: Article Affiliation country: Estados Unidos